JP2020520393A5 - - Google Patents

Download PDF

Info

Publication number
JP2020520393A5
JP2020520393A5 JP2019558350A JP2019558350A JP2020520393A5 JP 2020520393 A5 JP2020520393 A5 JP 2020520393A5 JP 2019558350 A JP2019558350 A JP 2019558350A JP 2019558350 A JP2019558350 A JP 2019558350A JP 2020520393 A5 JP2020520393 A5 JP 2020520393A5
Authority
JP
Japan
Prior art keywords
dendrimer
integer
composition
pamam
subject
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2019558350A
Other languages
English (en)
Japanese (ja)
Other versions
JP7178108B2 (ja
JP2020520393A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2018/029882 external-priority patent/WO2018201007A2/en
Publication of JP2020520393A publication Critical patent/JP2020520393A/ja
Publication of JP2020520393A5 publication Critical patent/JP2020520393A5/ja
Application granted granted Critical
Publication of JP7178108B2 publication Critical patent/JP7178108B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2019558350A 2017-04-27 2018-04-27 血管造影において使用するためのデンドリマー組成物 Active JP7178108B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201762490936P 2017-04-27 2017-04-27
US62/490,936 2017-04-27
PCT/US2018/029882 WO2018201007A2 (en) 2017-04-27 2018-04-27 Dendrimer compositions for use in angiography

Publications (3)

Publication Number Publication Date
JP2020520393A JP2020520393A (ja) 2020-07-09
JP2020520393A5 true JP2020520393A5 (cg-RX-API-DMAC7.html) 2021-05-27
JP7178108B2 JP7178108B2 (ja) 2022-11-25

Family

ID=63919237

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019558350A Active JP7178108B2 (ja) 2017-04-27 2018-04-27 血管造影において使用するためのデンドリマー組成物

Country Status (8)

Country Link
US (1) US11160881B2 (cg-RX-API-DMAC7.html)
EP (1) EP3615086A4 (cg-RX-API-DMAC7.html)
JP (1) JP7178108B2 (cg-RX-API-DMAC7.html)
CN (1) CN110913916A (cg-RX-API-DMAC7.html)
AU (1) AU2018258654B2 (cg-RX-API-DMAC7.html)
CA (1) CA3061630C (cg-RX-API-DMAC7.html)
IL (1) IL270169B2 (cg-RX-API-DMAC7.html)
WO (1) WO2018201007A2 (cg-RX-API-DMAC7.html)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RS67656B1 (sr) 2018-05-10 2026-02-27 Regeneron Pharma Formulacije koje sadrže visoke koncentracije fuzionog proteina vegf receptora
WO2021113662A2 (en) 2019-12-04 2021-06-10 Ashvattha Therapeutics, Inc. Dendrimer compositions and methods for drug delivery to the eye
CN112023061B (zh) * 2020-07-30 2022-07-12 东华大学 一种功能化树状大分子包裹金纳米颗粒/PD-L1 siRNA复合物及其制备和应用

Family Cites Families (42)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
RU2093165C1 (ru) 1993-07-06 1997-10-20 Линд Роберт Мейнгардтович Средство для лечения конъюнктивитов
US6355677B1 (en) 1998-09-28 2002-03-12 The Johns Hopkins University Adrenoleukodystrophy treatments and drug screening
US6312725B1 (en) 1999-04-16 2001-11-06 Cohesion Technologies, Inc. Rapid gelling biocompatible polymer composition
US20030180250A1 (en) 2002-03-22 2003-09-25 Council Of Scientific And Industrial Research Compositions and complexes containing a macromolecular compound as potential anti-inflammatory agents
US20040151754A1 (en) 2002-12-20 2004-08-05 Control Delivery Systems, Inc. Steroid suspensions for intraocular use
EP1689354A4 (en) 2003-11-20 2010-07-14 Othera Holding Inc REDUCTION OF CATARACTS, MACULAR GENERATION AND OTHER EYES DISEASES
US20050276917A1 (en) 2004-06-15 2005-12-15 Helene Bolm Process for the preparation of powder coatings
EP1676569A1 (en) 2004-12-30 2006-07-05 Pevion Biotech Ltd. Lyophilization of virosomes
CA2598430C (en) 2005-04-20 2011-10-25 Dendritic Nanotechnologies, Inc. Dendritic polymers with enhanced amplification and interior functionality
US7674781B2 (en) 2006-04-28 2010-03-09 Heather Sheardown Hyaluronic acid-retaining polymers
CN101495152A (zh) 2006-05-22 2009-07-29 艾伦药物公司 通过三信反应制备作为vla-4拮抗剂的聚合物结合物的方法
EP2214646B1 (en) 2007-10-05 2021-06-23 Wayne State University Dendrimers for sustained release of compounds
EP2261290B1 (en) 2008-04-04 2016-02-24 Konica Minolta IJ Technologies, Inc. Nonaqueous ink jet ink, process for producing nonaqueous ink jet ink, and ink jet recording method
WO2009142754A1 (en) 2008-05-22 2009-11-26 Goverment Of The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Dendritic conjugates and methods of use
US20100015231A1 (en) 2008-07-17 2010-01-21 E.I. Du Pont De Nemours And Company Low swell, long-lived hydrogel sealant
US8821870B2 (en) 2008-07-18 2014-09-02 Allergan, Inc. Method for treating atrophic age related macular degeneration
WO2010039861A2 (en) 2008-09-30 2010-04-08 The Regents Of The University Of Michigan Dendrimer conjugates
CA2767163A1 (en) 2009-06-15 2010-12-23 Wayne State University Dendrimer based nanodevices for therapeutic and imaging purposes
US20120177593A1 (en) 2009-07-20 2012-07-12 The Regents Of The University Of Michigan Synthesis of dendrimer conjugates
WO2011072290A2 (en) 2009-12-11 2011-06-16 The Regents Of The University Of Michigan Targeted dendrimer-drug conjugates
WO2011123591A1 (en) 2010-03-31 2011-10-06 Wayne State University Injectable dendrimer hydrogel nanoparticles
JP2013540748A (ja) 2010-09-16 2013-11-07 コーネル ユニバーシティー 血液脳関門の透過性を調節するためのアデノシン受容体シグナル伝達の使用法
WO2012142470A1 (en) 2011-04-13 2012-10-18 Massachusetts Institute Of Technology Biocompatible adhesive materials and methods
US20130123330A1 (en) 2011-07-15 2013-05-16 Patrick Y. Lu Dual Targeted siRNA Therapeutics for Treatment of Diabetic Retinopathy and Other Ocular Neovascularization Diseases
US20130165771A1 (en) * 2011-12-17 2013-06-27 Ming Ni Use of fitc-dextran as dye for fundus angiography and methods thereof
CN104781276A (zh) 2012-08-14 2015-07-15 安吉奥开米公司 肽-树枝状聚合物结合物及其用途
US20150352230A1 (en) 2013-01-11 2015-12-10 The Regents Of The University Of Michigan Synthesis and isolation of dendrimer based imaging systems
WO2014178892A1 (en) 2013-05-03 2014-11-06 Scanlan Thomas S Use of sobetirome in the treatment of x-linked adrenolenoleukodystrophy
AU2014276379A1 (en) 2013-06-07 2016-01-07 The Administrators Of The Tulane Educational Fund Analogs of pituitary adenylate cyclase-activating polypeptide (PACAP) and methods for their use
CN105813690A (zh) 2013-08-21 2016-07-27 协和大学 树状聚合物-白藜芦醇复合物
WO2015038493A1 (en) 2013-09-10 2015-03-19 The Research Foundation For The State University Of New York Synthesis of novel asymmetric bow-tie pamam dendrimer-based conjugates for tumor-targeting drug delivery
CN103804693B (zh) 2014-01-24 2016-03-09 中国科学院化学研究所 树枝状聚缩酮及其制备方法和应用
PL2922360T3 (pl) 2014-03-21 2019-06-28 Sun Patent Trust Procedura żądania planowania dla łączności D2D
EP3137116B1 (en) 2014-04-30 2020-12-16 The Johns Hopkins University Dendrimer compositions and their use in treatment of diseases of the eye
US11918695B2 (en) 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
CN103999853B (zh) 2014-06-11 2015-07-22 中国农业大学 荧光树枝状纳米大分子在制备药物载体中的应用
WO2016025745A1 (en) * 2014-08-13 2016-02-18 The Johns Hopkins University Dendrimer compositions and use in treatment of neurological and cns disorders
EP3180031A1 (en) 2014-08-13 2017-06-21 The Johns Hopkins University Selective dendrimer delivery to brain tumors
CN108289872B (zh) 2015-10-29 2021-04-02 约翰霍普金斯大学 树枝状聚合物组合物和其在坏死性小肠结肠炎和其它胃肠道病症治疗中的用途
CN108430514B (zh) 2015-10-29 2023-11-03 约翰霍普金斯大学 用于治疗过氧化物酶体病症和脑白质营养不良的组合物和方法
JP6986758B2 (ja) 2016-02-08 2021-12-22 ザ・ジョンズ・ホプキンス・ユニバーシティー デンドリマー−生体接着性ポリマーヒドロゲルナノ接着剤およびその使用
WO2019094952A1 (en) 2017-11-10 2019-05-16 The Johns Hopkins University Dendrimer delivery system and methods of use thereof

Similar Documents

Publication Publication Date Title
US20260098085A1 (en) Methods for treating age-related macular degeneration
JP7378638B2 (ja) チロシンキナーゼ阻害剤を含む眼内インプラント
JP5583146B2 (ja) レセプターチロシンキナーゼ阻害(RTKi)化合物の眼への送達のための薬学的組成物
JP2020502130A5 (cg-RX-API-DMAC7.html)
JP2022183183A (ja) 小さい活動性脈絡膜新生血管病変を有する加齢黄斑変性症の治療
JP6494528B2 (ja) フッ化インテグリンアンタゴニスト
WO2012061695A1 (en) Compositions and methods for the treatment of traumatic brain injury
Xin et al. Ophthalmic drops with nanoparticles derived from a natural product for treating age-related macular degeneration
JP2010523696A (ja) 脳腫瘍を治療する方法
WO2021048806A1 (en) Methods for treating ocular diseases
RU2015145134A (ru) Местное лечение воспалительных офтальмологических заболеваний
JP2021525875A5 (cg-RX-API-DMAC7.html)
JP2018536650A5 (cg-RX-API-DMAC7.html)
US11160881B2 (en) Dendrimer compositions for use in angiography
CN114727981B (zh) 用于挽救视网膜和脉络膜结构和功能的组合物和方法
WO2015175954A1 (en) Alpha v integrin antagonist compositions
JP2007521285A (ja) 眼障害の処置のためのクマリン誘導体
JP2016050181A (ja) 血管炎治療剤
RU2022102195A (ru) Новые способы лечения бокового амиотрофического склероза
US20120077744A1 (en) Steroid-sparing methods of treating brain edema
US20250387410A1 (en) Treatment of anti-vegf refractory ophthalmic retinal eye conditions
KR20170132176A (ko) 안과 질환을 치료하기 위한 화합물
WO2016189491A1 (en) Novel formulation
CN104370889A (zh) 一类降低眼压的化合物及其制备方法和用途